These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 28199142)

  • 1. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.
    Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T
    FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens.
    Mensah KA; Ritchlin CT; Schwarz EM
    J Cell Physiol; 2010 Apr; 223(1):76-83. PubMed ID: 20039274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis.
    Duarte C; Yamada C; Ngala B; Garcia C; Akkaoui J; Birsa M; Ho A; Nusbaum A; AlQallaf H; John V; Movila A
    Mol Oral Microbiol; 2024 Jun; 39(3):93-102. PubMed ID: 37902168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.
    Yang M; Birnbaum MJ; MacKay CA; Mason-Savas A; Thompson B; Odgren PR
    J Cell Physiol; 2008 May; 215(2):497-505. PubMed ID: 18064667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
    Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
    J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology.
    Witwicka H; Hwang SY; Reyes-Gutierrez P; Jia H; Odgren PE; Donahue LR; Birnbaum MJ; Odgren PR
    PLoS One; 2015; 10(6):e0128275. PubMed ID: 26042409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
    Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
    Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.
    Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M
    Biosci Biotechnol Biochem; 2017 Jun; 81(6):1220-1223. PubMed ID: 28136694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis.
    Shindo S; Pierrelus R; Ikeda A; Nakamura S; Heidari A; Pastore MR; Leon E; Ruiz S; Chheda H; Khatiwala R; Kumagai T; Tolson G; Elderbashy I; Ouhara K; Han X; Hernandez M; Vardar-Sengul S; Shiba H; Kawai T
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.
    Makihira S; Nikawa H; Kajiya M; Kawai T; Mine Y; Kosaka E; Silva MJ; Tobiume K; Terada Y
    Eur J Pharmacol; 2011 Nov; 670(2-3):409-18. PubMed ID: 21945676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.
    Kanzaki H; Movila A; Kayal R; Napimoga MH; Egashira K; Dewhirst F; Sasaki H; Howait M; Al-Dharrab A; Mira A; Han X; Taubman MA; Nichols FC; Kawai T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):452-462. PubMed ID: 28153611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous application of compressive force induces fusion of osteoclast-like RAW264.7 cells via upregulation of RANK and downregulation of LGR4.
    Matsuike R; Tanaka H; Nakai K; Kanda M; Nagasaki M; Murakami F; Shibata C; Mayahara K; Nakajima A; Tanabe N; Kawato T; Maeno M; Shimizu N
    Life Sci; 2018 May; 201():30-36. PubMed ID: 29572179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL-induced DC-STAMP is essential for osteoclastogenesis.
    Kukita T; Wada N; Kukita A; Kakimoto T; Sandra F; Toh K; Nagata K; Iijima T; Horiuchi M; Matsusaki H; Hieshima K; Yoshie O; Nomiyama H
    J Exp Med; 2004 Oct; 200(7):941-6. PubMed ID: 15452179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
    Valverde P; Kawai T; Taubman MA
    J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
    Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
    Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
    Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
    Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
    Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
    Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.